BMC Ophthalmology is associated with Cochrane Eyes and Vision
Double-dose investigation of aflibercept in neovascular age-related macular degeneration (DIANA): a real-world study
To investigate the clinical effects of double-dose (4 mg) aflibercept treatment in neovascular age-related macular degeneration (nAMD), compared with the standard-dose (2 mg) treatment.